DanCann Pharma A/S is a biopharmaceutical company, which engages in the business of discovering, developing, manufacturing, and commercializing new therapeutic cannabinoids in various disease areas. It operates under the Biomaterials and Import and Export of Medical Cannabis Products segments. The company was founded by Jeppe Krog Rasmussen on March 20, 2018 and is headquartered in Ansager, Denmark.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of DanCann Pharma A/S?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. DanCann Pharma A/S market cap is $39,900.00.
What is the 52-week high for DanCann Pharma A/S?
52 week high is the highest price of a stock in the past 52 weeks, or one year. DanCann Pharma A/S 52 week high is $10.00 as of October 01, 2025.
What is the 52-week low for DanCann Pharma A/S?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. DanCann Pharma A/S 52 week low is $0.01 as of October 01, 2025.
What is DanCann Pharma A/S stock price today?
DanCann Pharma A/S stock price today is $10.00.
What is the PE ratio of DanCann Pharma A/S?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. DanCann Pharma A/S’s P/E ratio is -0.02.
What is the Price-to-Book ratio of DanCann Pharma A/S?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. DanCann Pharma A/S P/B ratio is 0.0289.
What is the 50-day moving average of DanCann Pharma A/S?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. DanCann Pharma A/S 50-day moving average is $0.01.